West Pharmaceutical Services (WST)
R&D Expenses
$19.70M
Quarterly · Period ending: · USD
WST R&D Expenses
Latest reported$19.70Mperiod ending
Latest reported$19.70Mperiod ending
WST Quarterly R&D Expenses ($0.00 → $19.70M)
Quarterly R&D Expenses
High-resolution chart · PNG
WST r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 19,700,000 | |
| 15,800,000 | |
| 21,800,000 | |
| 17,100,000 | |
| 19,100,000 | |
| 16,300,000 | |
| 18,500,000 | |
| 15,500,000 | |
| 17,500,000 | |
| 17,600,000 | |
| 18,400,000 | |
| 16,399,999 | |
| 16,500,000 | |
| 17,100,000 | |
| 15,900,000 | |
| 13,600,000 | |
| 14,400,000 | |
| 14,600,000 | |
| 13,700,000 | |
| 13,100,000 | |
| 13,800,000 | |
| 12,200,000 | |
| 12,900,000 | |
| 12,500,000 | |
| 10,800,000 | |
| 10,700,000 | |
| 10,200,000 | |
| 9,300,000 | |
| 9,600,000 | |
| 9,800,000 | |
| 9,800,000 | |
| 10,100,000 | |
| 10,800,000 | |
| 9,600,000 | |
| 9,700,000 | |
| 9,100,000 | |
| 10,000,000 | |
| 10,300,000 | |
| 9,600,000 | |
| 9,000,000 | |
| 8,800,000 | |
| 9,400,000 | |
| 10,000,000 | |
| 8,500,000 | |
| 8,100,000 | |
| 7,500,000 | |
| 7,800,000 | |
| 9,600,000 | |
| 9,900,000 | |
| 10,000,000 | |
| 9,700,000 | |
| 9,600,000 | |
| 9,500,000 | |
| 9,100,000 | |
| 8,600,000 | |
| 8,200,000 | |
| 8,200,000 | |
| 8,300,000 | |
| 7,200,000 | |
| 7,700,000 | |
| 7,300,000 | |
| 6,900,000 | |
| 6,900,000 | |
| 5,900,000 | |
| 5,700,000 | |
| 5,400,000 | |
| 5,800,000 | |
| 5,100,000 | |
| 4,700,000 | |
| 4,300,000 | |
| 3,900,000 | |
| 4,600,000 | |
| 4,900,000 | |
| 5,400,000 | |
| 4,600,000 | |
| 4,100,000 | |
| 3,800,000 | |
| 3,600,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |